Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | MAPT | P10636 | 7/20 | 0.49 |
| ▸ | HPGD | P15428 | 7/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 2/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22058669 | 0.97 | MEN1 (0.46) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24255624 | 0.97 | MEN1 (0.46) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL17932709 | 0.97 | MEN1 (0.46) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL12133891 | 0.97 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL13492070 | 0.95 | MEN1 (0.45) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL12133796 | 0.95 | MEN1 (0.45) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL13889562 | 0.95 | PDK2 (0.44) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL16716650 | 0.95 | MEN1 (0.47) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22414232 | 0.95 | MEN1 (0.47) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL23846053 | 0.94 | PDK2 (0.44) | MEN1KMT2AALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6821643-B1 | SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS | XEROX CORPORATION | 2004-11-23 | — | — | US | claimed |
| US-6229012-B1 | ORGANIC ELECTROLUMINESCENT DEVICES | XEROX CORPORATION | 2001-05-08 | — | — | US | claimed |
| US-6225467-B1 | UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS | XEROX CORPORATION | 2001-05-01 | — | — | US | claimed |
| EP-3457450-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2024-06-12 | — | — | EP | disclosed |
| EP-2984152-B2 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2022-01-05 | — | — | EP | disclosed |
| EP-2627730-B1 | FORMULATIONS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-10636990-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| EP-2748878-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2020-04-01 | — | — | EP | disclosed |
| US-10377740-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| EP-2371016-B1 | ORGANIC LIGHT EMITTING EVICES COMPRISING TRIAZINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2019-08-07 | — | — | EP | disclosed |
| EP-3457450-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Merck Patent GmbH (DE) | 2019-03-20 | — | — | EP | disclosed |
| WO-2010102706-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2010-09-16 | — | — | WO | disclosed |
| US-7777407-B2 | Organic light emitting devices comprising a doped triazine electron transport layer | LG DISPLAY CO., LTD. (KR) | 2010-08-17 | — | — | US | disclosed |
| WO-2010072300-A1 | ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING TRIAZINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010015306-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH, (DE) | 2010-02-11 | — | — | WO | disclosed |
| US-20060251919-A1 | Organic light emitting devices | XEROX CORPORATION | 2006-11-09 | — | — | US | disclosed |
| US-20060251920-A1 | Organic light emitting devices comprising a doped triazine electron transport layer | XEROX CORPORATION | 2006-11-09 | — | — | US | disclosed |
| US-6821643-B1 | SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS | XEROX CORPORATION | 2004-11-23 | — | — | US | disclosed |
| US-6229012-B1 | ORGANIC ELECTROLUMINESCENT DEVICES | XEROX CORPORATION | 2001-05-08 | — | — | US | disclosed |
| US-6225467-B1 | UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS | XEROX CORPORATION | 2001-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10377740-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | MEN1 798/4885KMT2A 177/4885ALDH1A1 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.